- Home
- PRLD vs BZFD Comparison
PRLD vs BZFD Comparison
Compare PRLD & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- BZFD
- Stock Information
- Founded
- PRLD 2016
- BZFD 2006
- Country
- PRLD United States
- BZFD United States
- Employees
- PRLD N/A
- BZFD N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- BZFD Movies/Entertainment
- Sector
- PRLD Health Care
- BZFD Consumer Discretionary
- Exchange
- PRLD Nasdaq
- BZFD Nasdaq
- Market Cap
- PRLD 69.1M
- BZFD 64.1M
- IPO Year
- PRLD 2020
- BZFD N/A
- Fundamental
- Price
- PRLD $1.42
- BZFD $1.72
- Analyst Decision
- PRLD Strong Buy
- BZFD
- Analyst Count
- PRLD 3
- BZFD 0
- Target Price
- PRLD $4.00
- BZFD N/A
- AVG Volume (30 Days)
- PRLD 290.5K
- BZFD 288.7K
- Earning Date
- PRLD 11-05-2025
- BZFD 11-11-2025
- Dividend Yield
- PRLD N/A
- BZFD N/A
- EPS Growth
- PRLD N/A
- BZFD N/A
- EPS
- PRLD N/A
- BZFD 0.25
- Revenue
- PRLD $7,000,000.00
- BZFD $194,178,000.00
- Revenue This Year
- PRLD N/A
- BZFD $6.87
- Revenue Next Year
- PRLD N/A
- BZFD $6.21
- P/E Ratio
- PRLD N/A
- BZFD $6.78
- Revenue Growth
- PRLD N/A
- BZFD 1.38
- 52 Week Low
- PRLD $0.61
- BZFD $1.61
- 52 Week High
- PRLD $2.08
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- PRLD 60.29
- BZFD 32.15
- Support Level
- PRLD $1.33
- BZFD $1.66
- Resistance Level
- PRLD $1.63
- BZFD $1.80
- Average True Range (ATR)
- PRLD 0.18
- BZFD 0.06
- MACD
- PRLD 0.01
- BZFD 0.00
- Stochastic Oscillator
- PRLD 49.42
- BZFD 7.69
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.